Nuclein
About:
Nuclein is a biotechnology company that develops the polymerase chain reaction test device for infectious diseases.
Website: https://nuclein.com
Top Investors: Trinity Private Equity Group
Description:
Nuclein is a biotechnology company that develops the Hand-Held Polymerase Chain Reaction test device for infectious diseases. The test device is a disposable, all-in-one, self-testing device for infectious disease diagnosis that does not require any technical expertise and provides battery-powered, sample-to-answer results in under one hour, without the need to mail in a sample.
$28.8M
$1M to $10M
Austin, Texas, United States
2017-01-01
Alan Blake, Richard Crockett
11-50
2024-08-05
Private
© 2025 bioDAO.ai